Trial
NCT03370185
Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma
Phase IIWITHDRAWNSAFETYConfidence: HIGH
Sponsor
SecuraBio
Collaborators
—
Condition
Chronic Lymphocytic Leukemia
Intervention
Duvelisib
Why stopped
Reassessing corporate priorities.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-28